Advertisement

Amphetamine Induced Arousal in Human Subjects as a Model for Mania

  • David Jacobs

Abstract

One avenue for investigating the biological aspects of mania, is to use a pharmacological model and in the past a variety of animal models have been proposed. These experiments however risk being an over-simplification with the additional difficulty of extrapolation from one species to another. Furthermore, animal models allow no measure of the mental state, a necessity in research in the field of psychological illness.

Keywords

Fusaric Acid Visual Analogue Rating Scale Affective Illness Spontaneous Fluctuation Pharmacological Model 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (1).
    T Silverstone and J Cookson, The Biology of Mania, in: Recent Advances in Clinical Psychiatry, 4, edited by Granville-Grossman, 201–241, (1962).Google Scholar
  2. (2).
    J Scheelkruger, Some Aspects of the Mechanism of Action of various Stimulant Amphetamine Analogues, Psychiat Neurol Neurochir (Amst), 75, 179–192, (1972).Google Scholar
  3. (3).
    J Schildkraut, The Catecholamine Hypothesis of Affective Disorders: A Review of Supporting Evidence. Am J Psychiatry, 122, 509–522, (1965).PubMedGoogle Scholar
  4. (4).
    A Randrup, I Munkvad, R Fog, J Gerlach, L Molander, B Kjellberg, J Scheelkruger, Mania, Depression and Brain Dopamine, in: Current Developments Psychopharmacology, 2, Spectrum Publications, 205–248, (1975).Google Scholar
  5. (5).
    D Hemsley and H Philips, Models of Mania: An Individual Case Study, Brit J Psychiatry, 127, 78–85, (1975).CrossRefGoogle Scholar
  6. (6).
    D Jacobs and T Silverstone, Pimozide Inhibits and Thymoxamine Enhances D-Amphetamine Induced Arousal in Human Subjects, 13th CINP Congress, (1982).Google Scholar
  7. (7).
    G Ashcroft, D Eccleston, L Murray, A Glen, T Crawford, I Pullar, P Shields, D Walter, I Blackburn, J Connechan, M Lonergan, Modified Amine Hypothesis for the Aetiology of Affective Illness, Lancet, 573–577, (1972).Google Scholar
  8. (8).
    G Ashcroft, D Eccleston, J Waddell, Recognition of Amphetamine Addicts, Brit Med J, 1, 57, (1965).PubMedCrossRefGoogle Scholar
  9. (9).
    J Cookson, T Silverstone, G Besser, S Williams, Plasma Corticosteroids in Mania: The Effects of Pimozide, Neuropharmacology, 19, 1243–1244, (1980).PubMedCrossRefGoogle Scholar
  10. (10).
    G Besser, P Butler, J Landon, L Rees, Influence of Amphetamines on Plasma Corticosteroid and Growth Hormone Levels in Man, Brit Med J, 528–530, (1969).Google Scholar
  11. (11).
    H Brodie, D Murphy, F Goodwin, W Bunney (Jnr), Catecholamines and Mania: The Effect of Alpha-Methyl-Para- tyrosine on Manic Behaviour and Catecholamine Metabolism, Clinical Pharmacol Ther, 12(2), 218–224, (1971).Google Scholar
  12. (12).
    L Jonsson, E Anggard, L-M Günne, Blockade of IV Amphetamine Euphoria in Man, Clin Pharmacol Ther, 12, 889–896, (1971).PubMedGoogle Scholar
  13. (13).
    J Cookson, T Silverstone, B Wells, Double-Blind Comparative Clinical Trial of Pimozide and Chlorpromazine in Mania: A Test of the Dopamine Hypothesis, Acta Psych Scand, 64, 381–397, (1981).CrossRefGoogle Scholar
  14. (14).
    T Silverstone, J Fincham, B Wells, M Kyriakedes, The Effects of the Dopamine Receptor Blocking Drug Pimozide on the Stimulant and Anorectic Actions of Dextroamphetamine in Man, Neuropharmacology, 19, 1235–1237, (1980).PubMedCrossRefGoogle Scholar
  15. (15).
    M Schou, Special Review: Lithium in Psychiatric Therapy and Prophylaxis, J Psych Res., 6, 67–95, (1968).CrossRefGoogle Scholar
  16. (16).
    B Angrist and S Gershon, Variable Attenuation of Amphetamine Effects by Lithium, Am J Psychiatry, 136(6), 806–810, (1979).PubMedGoogle Scholar
  17. (17).
    R Pinder, R Brogden, P Sawyer, T Speight, R Spencer, G Avery, Pimozide—A Review of its Pharmacological Properties and Therapeutic Uses in Psychiatry, Drugs, 2, 1–40f (1976).CrossRefGoogle Scholar
  18. (18).
    J Roquebert, P Demichel, A Malek, Anti-noradrenergic Activity of Thymoxamine and its Metabolites in Rats, Arch int Pharmacodyn, 249, 12–25, (1981).PubMedGoogle Scholar
  19. (19).
    J Schildkraut and S Kety, Biogenic Amines and Emotion, Science, 156, 21–30, (1967).PubMedCrossRefGoogle Scholar
  20. (20).
    R Post, Biochemical Theories of Mania, in: Mania An Evolving Concept, edited by Belmaker and Van Praag, Spectrum Publications, New York, 217–265, (1980).Google Scholar
  21. (21).
    R Sack and F Goodwin; Inhibition of Dopamine B Hydroxylase in Manic Patients, Arch Gen Psychiatry, 31, 649–654, (1974).PubMedCrossRefGoogle Scholar
  22. (22).
    R Jouvent, Y Lecrubier, A Puech, P Simon, D Widlocher, Antimanic Effect of Clonidine, Am J Psychiatry, 137(10), 1275–1276, (1980).PubMedGoogle Scholar
  23. (23).
    H Emrich, D Vonzerssen, H Moller, W Kissling, C Cording, J Schietschilt, E Riedel, Action of Propanol in Mania: Comparison of the D and L Isomer, Pharmakopsychiat, 12(4), 294–304, (1979).CrossRefGoogle Scholar
  24. (24).
    L Arnold, P Wender, K McCloskey, S Snyder, Levo-amphetamine and Dextroamphetamine: Comparative Efficacy in the Hyperkinetic Syndrome, Arch Gen Psychiatry, 27, 816–822, (1972).PubMedCrossRefGoogle Scholar
  25. (25).
    D Van Kämmen, W Bunney, J Docherty, S Marder, M Ebert, J Rosenblatt, J Rayner, d-Amphetamine Induced Heterogenous Changes in Psychotic Behaviour in Schizophrenia, Am J Psychiatry, 139(8), 991–997, (1982).PubMedGoogle Scholar
  26. (26).
    Von H Beckman and H Heineman, D-Amphetamine Beim Manischen Syndrom, Arzheimittel Forsch, 26(6), 1185–1186, (1976).Google Scholar
  27. (27).
    S Antelman and A Caggiula, Norepinephrine — Dopamine Interactions and Behaviour, Science, 195, 646–653, (1977).PubMedCrossRefGoogle Scholar
  28. (28).
    A Cools and J van Rossum, Multiple Receptors for Brain Dopamine in Behavioural Regulation Concept of Dopamine E and Dopamine I Receptors, Life Sciences, 27(14), 1237–1253, (1980).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • David Jacobs
    • 1
  1. 1.Department of Postgraduate Education in Psychiatry UnitSelby CentreShenton ParkAustralia

Personalised recommendations